In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 3, 2000, Pages 601-609

  Santin, Alessandro D ^a,b   Hermonat, Paul L ^a   Ravaggi, Antonella ^a,b   Bellone, Stefania ^a,b   Pecorelli, Sergio ^b   Cannon, Martin J ^a   Parham, Groesbeck P ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; Ovarian cancer; Tumor lysate

Indexed keywords

CD56 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A;

ADVANCED CANCER; ANTIGEN SPECIFICITY; ARTICLE; CELL LYSATE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; OVARY CANCER; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS TRANSFORMATION;

EID: 0033829658     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107097     Document Type: Article

References (25)

1. Epithelial ovarian cancer
2. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA
3. Ovarian and breast CTL can recognize peptides from the AES protein of the notch complex
4. Association of Her-2/neu expression with sensitivity to tumor specific CTL in human ovarian cancer
5. Antigen-presenting cells pulsed with tumor unfractionated tumor-derived peptides are potent tumor vaccines
6. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
7. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
8. Dendritic cells pulsed with RNA are potent antigen presenting in vitro and in vitro
9. The dendritic cell system and its role in immunogenicity
10. Effects of tumor necrosis factor-alfa plus interferon-gamma combined with high dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 human ovarian cancers
11. Induction of human papillomavirus-specific CD4+ and CD8+ lymphocytes by E7 pulsed autologous dendritic cells in patients with HPV16 and 18 positive cervical cancer
12. Cytolytic effector function in human circulating CD8+ T cells closely correlated with CD56 surface expression
13. Identification of T-cell epitope: Rapid isolation of class I-presented peptides from viable cells by mild acid elution
14. Shared T cell epitopes in epithelial tumors
15. Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes
16. Human T(H)1 and T(H)2 subsets: Regulation of differentiation and role in protection and immunopathology
17. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth
18. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology
19. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity
20. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer
21. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity
22. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
23. Paracrine cytokine adjuvants in cancer immunotherapy
24. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
25. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells